Benfotiamine.
Fat-soluble B1. Better for nerves than regular thiamine. Fat-soluble B1 that gets absorbed 5x better than regular thiamine. Protects nerves and helps metabolize glucose.
Reviewed March 2026
- Category
- Vitamin
- Also filed under
- NervesNeuropathyGlucose metabolism
What Benfotiamine is, and what it does.
- Does it work
- Yes, especially for metabolic or nerve issues. If you need B1, this is the form to use.
- How much to take
- 150-300mg daily. Can go higher for therapeutic purposes. Much more effective than high-dose regular B1.
- Time to feel it
- Blood thiamine rises within hours of the first dose. Anything you would notice builds over weeks, and status is read on a thiamine or red cell transketolase panel.
- The first dose
- Blood thiamine climbs within hours of the first capsule. Nothing in your day changes yet, and what has moved is a lab value feeding the enzymes that run carbohydrate metabolism.
- With regular use
- Improved nerve function, protection against glycation, better glucose metabolism.
- How well tolerated
- Well tolerated. Water-soluble vitamins have wide safety margins. This is just a better-absorbed version.
- How it feels
- Those with neuropathy often notice reduced symptoms. Otherwise subtle.
- The overlooked benefit
- Thiamine only becomes active after a magnesium and ATP dependent phosphorylation step, so your magnesium status quietly sets the ceiling on what any B1 form can do.
150 to 300mg a day is where Benfotiamine works.
Source: Stracke et al. (2008) Diabetes Care; Haupt et al. (2005) Int J Clin Pharmacol Ther
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 25 human trials with 70% consistency.
- Raising blood and tissue thiamine levelsRandomised trial
- Red blood cell transketolase activityRandomised trial
- Nerve comfort in the hands and feetRandomised trial
- Advanced glycation end product formationRandomised trial
- Markers of normal glucose handlingRandomised trial
Questions people ask about Benfotiamine.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Benfotiamine is a lipid-soluble thiamine prodrug that is dephosphorylated to S-benzoylthiamine and bypasses the saturable intestinal thiamine transporter that limits water-soluble thiamine at higher doses. Stacking the two overlaps on one vitamin rather than adding a second nutrient.
Thiamine pyrophosphokinase needs magnesium to convert thiamine into thiamine diphosphate, and the diphosphate-dependent enzymes bind magnesium at their active sites. Without adequate magnesium a thiamine dose is poorly converted into the working cofactor.
Pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase each need thiamine diphosphate and a lipoamide arm to move the substrate through the complex. The pairing rests on that shared enzyme architecture.
The same dehydrogenase complexes that use thiamine diphosphate also require FAD, which comes from riboflavin, to reoxidise the lipoamide arm. A shortfall in either cofactor stalls the whole complex.
Pyruvate and alpha-ketoglutarate dehydrogenase pass electrons to NAD, which niacin supplies, after the thiamine diphosphate step has done its work. Both vitamins are needed for one continuous reaction.
Pantothenic acid builds coenzyme A, which accepts the acyl group that the thiamine diphosphate step generates in these complexes. The five-cofactor set is textbook and incomplete if any member is missing.
Cobalamin supports the methylation chemistry behind myelin upkeep while thiamine diphosphate supports the carbohydrate oxidation a nerve cell runs on. B1, B6 and B12 have been formulated together for nerve support on that split.
Pyridoxal phosphate runs the transamination and neurotransmitter steps of nerve metabolism while thiamine diphosphate runs the carbohydrate oxidation side. Nerve formulas keep B6 moderate, since high intakes carry their own upper limit.
Carnitine carries fatty acids into the mitochondrion while thiamine diphosphate gates entry of glucose-derived pyruvate into the same cycle. The pair covers both fuel routes.
Biotin-dependent pyruvate carboxylase and thiamine-dependent pyruvate dehydrogenase draw on the same pyruvate pool and route it either to oxidation or to replenishing the cycle. Covering both keeps that branch point supplied.
Thiamine diphosphate enzymes feed reducing equivalents into the respiratory chain, where coenzyme Q10 carries electrons onward. Each addresses a different stage of the same pathway.
Water-soluble thiamine salts depend on the saturable ThTr1 and ThTr2 transporters in the intestine, which caps how much a single large dose can deliver. Benfotiamine is dephosphorylated at the brush border and crosses less dependently on that transporter. Taken together they contribute to one thiamine total rather than two separate ones.
Thiamine diphosphate is the cofactor for transketolase, and transketolase activity is what routes sugar phosphates through the non-oxidative pentose phosphate pathway. The oxidative arm of that same pathway generates NADPH, which glutathione reductase uses to return oxidised glutathione to its active form. The link is biochemical and does not require a combination trial.
NAC supplies the rate-limiting cysteine for glutathione synthesis while thiamine-dependent transketolase feeds the NADPH that keeps that glutathione reduced. One provides the material, the other supports the recycling. Both parts are established individually; the pairing has not been measured as such.
Thiamine diphosphate is required by pyruvate dehydrogenase for glucose-derived carbon to enter the citric acid cycle, while carnitine governs long-chain fatty acid entry. The two cover the two main fuel routes into the same mitochondrion. Presented as complementary biochemistry, not a tested combination.
The benzoyl substitution makes benfotiamine less water-loving than thiamine hydrochloride, which is part of why it disperses differently in the gut. A lipid carrier is used in some formats on that basis. The practical size of any absorption difference from the vehicle has not been quantified.
Activated charcoal binds a wide range of small molecules indiscriminately, including vitamins, and does not distinguish a supplement from anything else in the lumen. Taken in the same window it can reduce how much benfotiamine is available for absorption. Separating them by several hours avoids the overlap.
Thiamine diphosphate dependent enzymes sit at key branch points of glucose oxidation, and berberine acts on cellular energy sensing that also affects glucose uptake. Combined, the direction of effect on blood glucose is additive rather than opposing. Anyone monitoring blood glucose should account for both being present.
Nothing specific on file for Benfotiamine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Benfotiamine actually does.
Benfotiamine is S-benzoylthiamine O-monophosphate, a synthetic thiamine derivative in which the thiazole ring is opened and carries a benzoyl group on the sulfur.
It acts as a prodrug: intestinal alkaline phosphatase removes the phosphate at the brush border, giving S-benzoylthiamine, which is then debenzoylated to thiamine inside cells and in the bloodstream.
Thiamine is phosphorylated to thiamine diphosphate, which is the required cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase and transketolase.
Transketolase moves two-carbon units between sugar phosphates, connecting glycolysis to the pentose phosphate pathway, and its activity in red blood cells is the classical functional assay of thiamine status.
Where Benfotiamine comes from.
Benfotiamine starts as ordinary vitamin B1. Chemists open one of its rings, attach a benzoyl group to the sulfur that this exposes, and add a phosphate, which turns it into a molecule the gut handles differently. Nothing is extracted from a plant, though similar sulfur-modified B1 compounds do turn up naturally in garlic and onions.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Synthetic thiamine, itself built from a pyrimidine and a thiazole fragment, is the starting material
Base opens the thiazole ring of thiamine, exposing a free thiol group on the resulting open-chain thiol form
Benzoyl chloride reacts with the exposed thiol to install the benzoyl group that defines the S-acyl thiamine class
A phosphate group is placed on the hydroxyethyl side chain, giving S-benzoylthiamine O-monophosphate
The product is crystallised out and washed to remove reagent residues and reaction by-products
Dried and milled for encapsulation or tabletting, assayed by HPLC against a reference standard
Getting Benfotiamine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A published protocol for a 12-month double-blind placebo-controlled trial of benfotiamine; it describes the planned design and endpoints and reports no results.Randomised trial. Bönhof GJ et al., 2022 (BMJ Open). PMID 35115359 ↗
- Change in psychiatric symptom scores after benfotiamine differed by lifetime severity of alcohol use and by sex, with the reported signal confined to males; a subgroup finding from a small trial.Randomised trial. Manzardo AM et al., 2015 (Drug and Alcohol Dependence). PMID 25908323 ↗
- Benfotiamine raised muscle thiamine content and shifted energy-metabolism enzyme measures in endurance-trained mice; a rodent tissue finding.Animal study. Gonçalves AC et al., 2024 (Journal of Nutrition and Metabolism). PMID 39364430 ↗
- Benfotiamine supplementation lowered oxidative stress markers in skeletal and cardiac muscle tissue in an exercise model; tissue markers in animals, not a human outcome.Animal study. Gonçalves AC et al., 2019 (Journal of Integrative Medicine). PMID 31395444 ↗
- A critical review of the mechanistic rationale for combining alpha-lipoic acid with benfotiamine in nerve function support; the authors report the mechanism is plausible while controlled human data for the combination remains limited.Narrative review. Ciubotaru A et al., 2026 (Nutrients). PMID 42196997 ↗
- Pooled trials of thiamine supplementation and blood glucose markers in adults with high blood sugar, with benfotiamine named among the forms used; glycaemic laboratory markers, and the pooled trials differ in form and dose.Meta-analysis. Muley A et al., 2022 (BMJ Open). PMID 36008064 ↗
- A placebo-controlled trial of a multi-ingredient product containing benfotiamine in healthy adults with everyday aches; because several actives were combined, the design cannot isolate benfotiamine's contribution.Randomised trial. Evans M et al., 2020 (Nutrients). PMID 32575480 ↗
- A published pilot trial protocol targeting glycation stress in postmenopausal women in which benfotiamine appears among the named interventions; protocol only, no results reported.Randomised trial. Tanwar V et al., 2026 (npj Aging). PMID 42026060 ↗
- A mechanistic review proposing thiamine as a modulator of the nuclear receptor PPAR gamma, drawing on modelling and preclinical work rather than human results.Narrative review. Panati K et al., 2025 (Frontiers in Pharmacology). PMID 41368574 ↗
- A comparison of thiamine with a lipid-modified thiamine derivative for uptake and activity in fruit flies; an invertebrate model that speaks to derivative chemistry, not to human dosing.Animal study. Nevermann S et al., 2026 (Frontiers in Nutrition). PMID 42421918 ↗
- A review of inflammatory markers in adults with high blood sugar and vascular complications that names benfotiamine among the interventions surveyed; descriptive, with no pooled effect estimate.Narrative review. Nwadiugwu MC et al., 2020 (Frontiers in Public Health). PMID 33569370 ↗
These are the studies our verdict leans on, chosen from the 11 we read for Benfotiamine. The full linked list is below.
The studies, linked.
12 sources behind our Benfotiamine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialThe Effectiveness of Benfotiamine in Reducing Abusive Drinking Among Family History Positive and Negative AlcoholicsClinicalTrials.gov ↗PHASE4 · 120 participants · Completed
- Clinical trialA Double-Blind Clinical Trial of Benfotiamine Treatment in Diabetic NephropathyClinicalTrials.gov ↗PHASE4 · 86 participants · Completed
- Clinical trialBenfotiamine in Alzheimer's Disease: A Pilot StudyClinicalTrials.gov ↗PHASE2 · 71 participants · Completed
- Clinical trialCan Oral Benfotiamine Supplementation Influence Progression of Microvascular Complications in Patients With Type 1 Diabetes?ClinicalTrials.gov ↗PHASE1 · 67 participants · Completed
- Clinical trialAcute Effects of a Low-AGE vs. High-AGE Meal on Postprandial Endothelial Function in People With Type 2 Diabetes Mellitus. Protective Effects of BenfotiamineClinicalTrials.gov ↗PHASE4 · 21 participants · Completed
- Clinical trialThe Role of the Glucosamine Pathway and Reactive Oxygen Species in the Pathogenesis of Diabetic ComplicationsClinicalTrials.gov ↗NA · 21 participants · Completed
- Clinical trialBenfotiamine Prevents Vascular Dysfunction in Healthy SmokersClinicalTrials.gov ↗PHASE3 · 20 participants · Completed
- Clinical trialA Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo- Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)ClinicalTrials.gov ↗PHASE2 · 406 participants · Active not recruiting
- Clinical trialA 12-Week Double-blind Randomized Controlled Study; Comparing the Efficacy of Benfotiamine and Vitamin b1-6-12 in Alleviating Numbness, Sensory Neuropathy Symptoms and Pain in Patients With Diabetic Peripheral NeuropathyClinicalTrials.gov ↗PHASE4 · 66 participants · Recruiting
- Clinical trialEffects of a Chronical Treatment With Benfotiamine in People With Type 2 Diabetes Mellitus on Pre- and Postprandial Endothelial Function, as Well as on the Function of the Autonomic Nervous SystemClinicalTrials.gov ↗PHASE4 · 30 participants · Unknown
- Clinical trialEffects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)and Diabetic Neuropathy in Subjects With Sensorimotor Diabetic Polyneuropathy: a Double-blind, Randomized, Placebo-controlled Parallel Group Pilot Study Over 12 Months.ClinicalTrials.gov ↗PHASE3 · 22 participants · Unknown
- Clinical trialA Combined Phase 1 + 2 Clinical Trial Evaluating the Safety and Efficacy of BC-DN-01 in the Treatment of Painful Diabetic Peripheral NeuropathyClinicalTrials.gov ↗PHASE1 · Withdrawn
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 5,656 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Benfotiamine is, not how risky it is. A report is not proof Benfotiamine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.